4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism
Autor: | E. A. Carrey, Anthony M. Marinaki, S. M. Edbury, R. T. Smolenski, H. A. Simmonds, David Goldsmith, Arian Laurence |
---|---|
Rok vydání: | 2007 |
Předmět: |
medicine.medical_specialty
Erythrocytes Nucleotides Chemistry Tryptophan Dehydrogenase General Medicine medicine.disease General Biochemistry Genetics and Molecular Biology Uremia Transplantation chemistry.chemical_compound Endocrinology Biochemistry Internal medicine medicine Humans Kidney Failure Chronic NAD+ kinase Molybdenum cofactor Aldehyde oxidase Chromatography High Pressure Liquid Quinolinic acid |
Zdroj: | Clinical and Experimental Medicine. 7:135-141 |
ISSN: | 1591-9528 1591-8890 |
Popis: | We recently identified an erythrocyte nucleotide accumulating in end-stage renal disease as 4-pyridone-3-carboxamide ribonucleotide triphosphate (4PYTP), a nucleotide never described previously. Plasma tryptophan concentration has been previously reported to be reduced in patients in chronic renal failure that is in turn associated with elevated precursors of tryptophan metabolism, including L -kynurenine and quinolinic acid, both of which have been implicated in the neurotoxic manifestations of chronic renal failure. Here we compare mean erythrocyte 4PYTP, and plasma tryptophan concentrations, in controls and four patient groups with renal impairment (10 per group) and confirmed a reduction in plasma tryptophan in patients on dialysis that corrected with renal transplantation. We found: An inverse correlation between plasma tryptophan and red cell 4PYTP concentrations (R(2)=0.44, P0.001) when all patients were grouped together. Restoration of both tryptophan and 4PYTP concentrations to control values was only achieved following renal transplantation. 4PYTP was absent from erythrocytes in Molybdenum cofactor (MoCF) deficiency implicating aldehyde oxidase/dehydrogenase, a Molybdenum requiring enzyme. High 4PYTP erythrocyte concentrations in adenine or hypoxanthine-phosphoribosyltransferase deficient patients in severe uremia (113 microM and 103 microM), confirmed the lack of involvement of either enzyme in 4PYTP formation. We propose that 4PYTP is formed by a novel route involving the oxidation of the intermediates of NAD turnover from quinolinic acid by aldehyde oxidase. |
Databáze: | OpenAIRE |
Externí odkaz: |